ArticleCase reports in oncology

Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab.

Sergey V Orlov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.